Poly Medicure Limited Stock
Equities
POLYMED
INE205C01021
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,451.10 INR | -0.76% |
|
+5.89% | -18.28% |
| Feb. 09 | IIFL Downgrades Poly Medicure to Reduce from Add; Price Target is INR1,230 | MT |
| Feb. 06 | Poly Medicure Limited, Q3 2026 Earnings Call, Feb 06, 2026 |
| Capitalization | 148B 1.59B 1.36B 1.26B 1.18B 2.2B 2.25B 14.74B 5.77B 71.17B 5.98B 5.85B 254B | P/E ratio 2026 * |
42.5x | P/E ratio 2027 * | 38.1x |
|---|---|---|---|---|---|
| Enterprise value | 137B 1.48B 1.26B 1.16B 1.1B 2.04B 2.08B 13.64B 5.34B 65.89B 5.54B 5.42B 235B | EV / Sales 2026 * |
7.32x | EV / Sales 2027 * | 6.04x |
| Free-Float |
32.64% | Yield 2026 * |
0.33% | Yield 2027 * | 0.36% |
Last Transcript: Poly Medicure Limited
| 1 day | -0.76% | ||
| 1 week | +5.89% | ||
| Current month | +21.86% | ||
| 1 month | +15.10% | ||
| 3 months | -15.35% | ||
| 6 months | -22.13% | ||
| Current year | -18.28% |
| 1 week | 1,345.05 |  | 1,476.5 |
| 1 month | 1,184 | | 1,476.5 |
| Current year | 1,184 | | 1,838.8 |
| 1 year | 1,184 | | 2,936.7 |
| 3 years | 921 | | 3,350 |
| 5 years | 652.3 | | 3,350 |
| 10 years | 130.1 | | 3,350 |
| Manager | Title | Age | Since |
|---|---|---|---|
Himanshu Baid
CEO | Chief Executive Officer | 57 | 2010-01-12 |
| Director of Finance/CFO | - | 2021-06-30 | |
| Chief Operating Officer | 58 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 88 | 2005-05-25 | |
| Director/Board Member | 84 | 2010-01-12 | |
Rishi Baid
BRD | Director/Board Member | 53 | 1995-03-29 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | +5.89% | -35.25% | +55.88% | 1.59B | |
| -2.36% | -2.50% | -20.95% | -2.20% | 175B | |
| -0.80% | +0.67% | +5.20% | +7.92% | 112B | |
| -0.51% | -1.23% | +12.83% | +93.94% | 62.41B | |
| -1.09% | +4.33% | +91.97% | +103.56% | 62.17B | |
| -0.80% | -0.19% | -23.57% | -39.25% | 43.91B | |
| -0.20% | +2.98% | - | - | 37.01B | |
| -2.53% | +2.89% | -3.21% | -44.24% | 24.64B | |
| -0.52% | +1.77% | +0.67% | +15.02% | 21.83B | |
| -0.23% | -2.36% | -20.25% | +11.93% | 19.83B | |
| Average | -0.98% | +1.88% | +0.83% | +22.51% | 56B | |
| Weighted average by Cap. | -1.29% | +0.32% | +3.60% | +20.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.73B 201M 172M 159M 150M 279M 284M 1.86B 729M 9B 756M 740M 32.05B | 22.58B 243M 207M 191M 180M 336M 343M 2.25B 879M 10.84B 911M 892M 38.64B |
| Net income | 3.49B 37.53M 31.97M 29.59M 27.86M 51.9M 52.96M 347M 136M 1.68B 141M 138M 5.97B | 3.91B 42.08M 35.85M 33.17M 31.24M 58.18M 59.37M 389M 152M 1.88B 158M 155M 6.7B |
| Net Debt | -11B -118M -101M -93.29M -87.84M -164M -167M -1.09B -428M -5.28B -444M -435M -18.83B | -11.91B -128M -109M -101M -95.03M -177M -181M -1.18B -463M -5.72B -480M -470M -20.37B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-13 | 1,451.10 ₹ | -0.76% | 5,822 |
| 26-04-10 | 1,462.20 ₹ | +1.80% | 4,500 |
| 26-04-09 | 1,436.40 ₹ | -0.16% | 3,301 |
| 26-04-08 | 1,438.65 ₹ | +3.61% | 10,517 |
| 26-04-07 | 1,388.55 ₹ | +1.33% | 12,167 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- POLYMED Stock
Select your edition
All financial news and data tailored to specific country editions
